Top

Published in:

01-05-2012 | Biological Psychiatry - CONy Pro/Con debate

Should magnesium be given to every migraineur? No

Authors: Arpad Pardutz, Laszlo Vecsei

Published in: Journal of Neural Transmission | Issue 5/2012

Abstract

Migraine is one of the most common neurological disorders that affects young people, causing a considerable degree of disability in the active population, with an enormous consequent socio-economic impact. Despite intensive research, the pathomechanism of migraine is not completely understood and its fully effective therapy remains to be achieved. A number of experimental studies have implicated the importance of magnesium ion in the pathophysiology of this condition. Magnesium has been also administered for both prophylactic and acute therapy in migraine, but the question of its efficacy has not been studied adequately. The data available suggest that magnesium has a potential role in the prophylaxis, but the results in acute therapy are far less convincing. With a good side effect profile, magnesium is a relatively safe drug with a possible beneficial effect in the prophylaxis of migraine headache, and it may have its niche in the treatment of migraine patients. However, the current medical evidence that has accumulated and the fact that there are far more effective treatment possibilities clearly indicate that this drug is definitely not to be used by every migraineur.

Andersson KE, Vinge E (1990) Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 39:355–373PubMedCrossRef

Banai S, Tzivoni D (1993) Drug therapy for torsade de pointes. J Cardiovasc Electrophysiol 4:206–210PubMedCrossRef

Barbiroli B, Montagna P, Cortelli P, Martinelli P, Sacquegna T, Zaniol P, Lugaresi E (1990) Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia 10:263–272PubMedCrossRef

Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, Pierangeli G, Zaniol P, Lugaresi E (1992) Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42:1209–1214PubMed

Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22:345–353PubMedCrossRef

Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136–142PubMedCrossRef

Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–982PubMed

Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624PubMedCrossRef

Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C (2005) A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 25:199–204PubMedCrossRef

Ciarkowski SL, Stalburg CM (2010) Medication safety in obstetrics and gynecology. Clin Obstet Gynecol 53:482–499PubMedCrossRef

Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ (2001) Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 38:621–627PubMedCrossRef

Demirkaya S, Vural O, Dora B, Topcuoglu MA (2001) Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 41:171–177PubMedCrossRef

Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622–625PubMedCrossRef

Ebel H, Gunther T (1980) Magnesium metabolism: a review. J Clin Chem Clin Biochem 18:257–270PubMed

Elin RJ (1994) Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 102:616–622PubMed

Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16:968–981PubMedCrossRef

Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298–301PubMedCrossRef

Gallai V, Sarchielli P, Morucci P, Abbritti G (1993) Red blood cell magnesium levels in migraine patients. Cephalalgia 13:81–94CrossRef

Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193–196PubMedCrossRef

Grubbs RD, Maguire ME (1987) Magnesium as a regulatory cation: criteria and evaluation. Magnesium 6:113–127PubMed

Guerrera MP, Volpe SL, Mao JJ (2009) Therapeutic uses of magnesium. Am Fam Physician 80:157–162PubMed

Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, Berbano E, O’Malley PG (2010) Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ 341:c5222PubMedCrossRef

Koseoglu E, Talaslioglu A, Gonul AS, Kula M (2008) The effects of magnesium prophylaxis in migraine without aura. Magnes Res 21:101–108PubMed

Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258–265PubMedCrossRef

Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117:199–210PubMedCrossRef

Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657PubMedCrossRef

Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885–890PubMedCrossRef

Mathew PJ, Muthurajan N, Wig J (2010) Progressive muscle weakness with respiratory insufficiency in a young patient with tetanus during magnesium sulfate infusion. Acta Anaesthesiol Taiwan 48:152–154PubMedCrossRef

Mauskop A, Altura BT, Cracco RQ, Altura BM (1993) Deficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio. Headache 33:135–138PubMedCrossRef

Mayer ML, Westbrook GL, Guthrie PB (1984) Voltage-dependent block by Mg²⁺ of NMDA responses in spinal cord neurones. Nature 309:261–263PubMedCrossRef

Moskowitz MA, Nozaki K, Kraig RP (1993) Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13:1167–1177PubMed

Onalan O, Crystal E, Daoulah A, Lau C, Crystal A, Lashevsky I (2007) Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol 99:1726–1732PubMedCrossRef

Peikert A, Wilimzig C, Kohne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16:257–263PubMedCrossRef

Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Gobel H, Fischer M (1996) Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 16:436–440PubMedCrossRef

Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM (1989) Low brain magnesium in migraine. Headache 29:416–419PubMedCrossRef

Rothrock JF (1997) Clinical studies of valproate for migraine prophylaxis. Cephalalgia 17:81–83PubMedCrossRef

Rude RK, Shils ME (2006) Magnesium. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ (eds) Modern Nutrition in Health and Disease, 10th edn. Lippincott Williams & Wilkins, Baltimore, pp 223–248

Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713–715PubMedCrossRef

Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466–470PubMed

Smeets MC, Vernooy CB, Souverijn JH, Ferrari MD (1994) Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura. Cephalalgia 14:29–32PubMedCrossRef

Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560–564PubMedCrossRef

Taubert K (1994) Magnesium in migraine. Results of a multicenter pilot study. Fortschr Med 112:328–330PubMed

Trauninger A, Pfund Z, Koszegi T, Czopf J (2002) Oral magnesium load test in patients with migraine. Headache 42:114–119PubMedCrossRef

Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601–610PubMedCrossRef

Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658–660PubMedCrossRef

Welch KM, Levine SR, D’Andrea G, Schultz LR, Helpern JA (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39:538–541PubMed

Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629–637PubMedCrossRef

Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17:518–524PubMedCrossRef

Witlin AG, Sibai BM (1998) Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 92:883–889PubMedCrossRef

Young WB, Siow HC, Silberstein SD (2004) Anticonvulsants in migraine. Curr Pain Headache Rep 8:244–250PubMedCrossRef

Title: Should magnesium be given to every migraineur? No
Authors: Arpad Pardutz
Laszlo Vecsei
Publication date: 01-05-2012
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 5/2012
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-012-0791-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Should magnesium be given to every migraineur? No

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2012

Compensatory brain activation in children with attention deficit/hyperactivity disorder during a simplified Go/No-go task

Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay

On the origin of the triplet puzzle of homologies in receptor heteromers: toll-like receptor triplets in different types of receptors

Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms

Intra- and inter-cortical motor excitability in Alzheimer’s disease

Why all migraine patients should be treated with magnesium